MedTrace Logo

Cognitive Behavioral Therapy for Anxiety and Depression in COPD

NCT00545922 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2007-11-16

No results posted yet for this study

Summary

The purpose of this study was to examine the efficacy of manualized, short-term group cognitive behavioral therapy for COPD patients suffering from clinically significant symptoms of anxiety and/or depression.

Conditions

Interventions

BEHAVIORAL

Cognitive behavioral therapy

Seven weekly sessions (2 hrs) in groups

BEHAVIORAL

Minimal Telephone Contact

Telephone contact (max. 10 minutes) every other week during the 7-week intervention

Sponsors & Collaborators

  • University of Bergen

    lead OTHER

Principal Investigators

  • Inger Hilde Nordhus, Dr. philos · University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2007-11-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00545922 on ClinicalTrials.gov